Relationship between the epithelial expression of hMLH1, MDM2, and p63 and lower lip carcinogenesis

Journal of Oral Pathology and Medicine

Volumn 43, Issue 5, 2014, Pages 357-363

  De Oliveira, Denise Hélen Imaculada Pereira ^a   de Sousa Lopes, Maria Luiza Diniz ^a   de Santana Sarmento, Dmitry José ^b   Queiroz, Lélia Maria Guedes ^a   da Costa Miguel, Márcia Cristina ^a   da Silveira, Éricka Janine Dantas ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b Estadual University of Paraíba   (Brazil)

Author keywords

Cheilitis; Lip neoplasm; Oral cancer; Squamous cell carcinoma

Indexed keywords

MDM2 PROTEIN, HUMAN; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN MDM2; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

CANCER GRADING; CARCINOGENESIS; CHEILITIS; CHEMISTRY; COMPARATIVE STUDY; EPITHELIUM CELL; FEMALE; HUMAN; LIP; LIP TUMOR; MALE; METABOLISM; MIDDLE AGED; MOUTH MUCOSA; PATHOLOGY; PRECANCER; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CHEILITIS; DNA REPAIR ENZYMES; EPITHELIAL CELLS; FEMALE; HUMANS; LIP; LIP NEOPLASMS; MALE; MIDDLE AGED; MOUTH MUCOSA; NEOPLASM GRADING; NUCLEAR PROTEINS; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-MDM2; RETROSPECTIVE STUDIES; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84898822794     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12144     Document Type: Article

References (30)

1. de Souza Lucena EE, Costa DC, da Silveira EJ, Lima KC. Prevalence and factors associated to actinic cheilitis in beach workers. Oral Dis, 2012; 18: 575-9.
2. Souza RL, Fonseca-Fonseca T, Oliveira-Santos CC, et al. Lip squamous cell carcinoma in a Brazilian population: epidemiological study and clinicopathological associations. Med Oral Patol Oral Cir Bucal 2011; 16: 757-62.
3. Xavier FC, Takiya CM, Reis SR, Ramalho LM. p63 Immunoexpression in lip carcinogenesis. J Mol Hist 2009; 40: 131-7.
4. Czerninski R, Krichevsky S, Ashhab Y, Gazit D, Patel V, Ben-Yehuda D. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma. Oral Dis 2009; 15: 206-13.
5. Seifert M, Reichrath J. The role of the human DNA mismatch repair gene hMSH2 in DNA repair, cell cycle control and apoptosis: implications for pathogenesis, progression and therapy of cancer. J Mol Histol 2006; 37: 301-7.
6. Kohn KW, Pommier Y. Molecular interaction map of the p53 and Mdm2 logic elements, which control the Off-On switch of p53 in response to DNA damage. Biochem Biophys Res Commun 2005; 331: 816-27.
7. Chen YK, Hsue SS, Lin LM. Expression of p63 protein and mRNA in oral epithelial dysplasia. J Oral Pathol Med 2005; 34: 232-9.
8. Oncel S, Cosgul T, Calli A, Calli C, Pinar E. Evaluation of p53, p63, p21, p27, ki-67 in paranasal sinus squamous cell carcinoma and inverted papilloma. Indian J Otolaryngol Head Neck Surg 2011; 63: 172-7.
9. Bryne M. Is the invasive front of an oral carcinoma the most important area for prognostication? Oral Dis 1998; 4: 70-7.
10. Caldeira PC, Abreu MH, Batista AC, do Carmo MA. hMLH1 immunoexpression is related to the degree of epithelial dysplasia in oral leukoplakia. J Oral Pathol Med, 2011; 40: 153-9.
11. Fernandes AM, De Souza VR, Springer CR, et al. Tobacco and inflammation effects in immunoexpression of hMSH2 and hMLH1 in epithelium of oral mucosa. Anticancer Res, 2007; 27(4B): 2433-7.
12. Lima Gda S, Silva GF, Gomes AP, de Araújo LM, Salum FG. Diclofenac in hyaluronic acid gel: an alternative treatment for actinic cheilitis. J Appl Oral Sci 2010; 18: 533-7.
13. Markopoulos A, Albanidou-Farmaki E, Kayavis I. Actinic cheilitis: clinical and pathologic characteristics in 65 cases. Oral Dis 2004; 10: 212-6.
14. Ntomouchtsis A, Karakinaris G, Poulolpoulos A, et al. Benign lip lesions. A 10-year retrospective study. Oral Maxillofac Surg 2010; 14: 115-8.
15. Piñera-Marques K, Lorenço SV, Silva LF, Sotto MN, Carneiro PC. Actinic lesions in fishermen's lower lip: clinical, cytopathological and histopathologic analysis. Clinics (Sao Paulo) 2010; 65: 363-7.
16. Hasson O. Squamous cell carcinoma of the lower lip. J Oral Maxillofac Surg 2008; 66: 1259-62.
17. Casal D, Carmo L, Melancia T, Zagalo C, Cid O, Rosa-Santos J. Lip cancer: a 5-year review in a tertiary referral centre. J Plast Reconstr Aesthet Surg 2010; 63: 2040-5.
18. Ikehata H, Ono T. The mechanisms of UV mutagenesis. J Radiat Res 2011; 52: 115-25.
19. Narayanan DL, Saladi RN, Fox JL. Ultraviolet radiation and skin cancer. Int J Dermatol 2010; 49: 978-86.
20. Shia J, Ellis NA, Klimstra DS. The utility of immunohistochemical detection of DNA mismatch repair gene proteins. Virchows Arch 2004; 445: 431-41.
21. Ghosh A, Ghosh S, Maiti GP, et al. Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance. Cancer Sci 2010; 101: 1511-20.
22. Wei Q, Eicher SA, Guan Y, et al. Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer. Cancer Epidemiol Biomarkers Prev 1998; 7: 309-14.
23. Megha T, Ferrari F, Benvenuto A, et al. p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin. J Clin Pathol 2002; 55: 461-6.
24. Martínez A, Brethauer U, Borlando J, Spencer ML, Rojas IG. Epithelial expression of p53, mdm2 and p21 in normal lip and actinic cheilitis. Oral Oncol 2008; 44: 878-83.
25. de Freitas MCA, Ramalho LMP, Xavier FCA, Moreira ALG, Reis SRA. p53 and MDM2 protein expression in actinic cheilitis. J Oral Appl Scienc 2008; 16: 414-9.
26. Yanamoto S, Kawasaki G, Yoshitomi I, Mizuno A. p53, mdm2 and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors. Oral Sur Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 593-600.
27. Alkhalaf M, Ganguli G, Messaddeq N, Le Meur M, Wasylyk B. MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice. Oncogene 1999; 18: 1419-34.
28. Hsu HS, Chen HW, Kao CL, Wu ML, Li AF, Cheng TH. MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus. Ann Surg Oncol 2011; 18: 1469-77.
29. Flores ER, Sengupta S, Miller JB, et al. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 2005; 7: 363-73.
30. Thurfjell N, Coates PJ, Uusitalo T, et al. Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of head and neck. Int J Oncol 2004; 25: 27-35.